PIMCO Senior Loan Active Exchange-Traded Fund (NYSEARCA:LONZ – Get Free Report) was the target of a significant decline in short interest in the month of October. As of October 15th, there was short interest totaling 109,042 shares, a decline of 37.8% from the September 30th total of 175,170 shares. Based on an average trading volume of 111,541 shares, the days-to-cover ratio is presently 1.0 days. Approximately 0.8% of the shares of the company are short sold.
PIMCO Senior Loan Active Exchange-Traded Fund Price Performance
NYSEARCA:LONZ traded down $0.19 during trading hours on Monday, hitting $48.57. 19,695 shares of the company traded hands, compared to its average volume of 94,281. PIMCO Senior Loan Active Exchange-Traded Fund has a twelve month low of $48.55 and a twelve month high of $50.81. The firm has a 50-day moving average of $49.03 and a 200 day moving average of $49.38.
Institutional Inflows and Outflows
A hedge fund recently bought a new position in PIMCO Senior Loan Active Exchange-Traded Fund stock. Concurrent Investment Advisors LLC bought a new stake in PIMCO Senior Loan Active Exchange-Traded Fund (NYSEARCA:LONZ – Free Report) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 41,068 shares of the company’s stock, valued at approximately $1,245,000. Concurrent Investment Advisors LLC owned 0.35% of PIMCO Senior Loan Active Exchange-Traded Fund as of its most recent filing with the Securities and Exchange Commission (SEC).
PIMCO Senior Loan Active Exchange-Traded Fund Company Profile
The PIMCO Senior Loan Active Exchange-Traded Fund (LONZ) is an exchange-traded fund that mostly invests in high yield fixed income. The fund seeks current income through the active management of US dollar-denominated senior floating rate bank loans that are rated below investment grade. LONZ was launched on Jun 8, 2022 and is managed by PIMCO.
Further Reading
- Five stocks we like better than PIMCO Senior Loan Active Exchange-Traded Fund
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
- Mortgage Rates Froze U.S. Housing, But These 3 Overseas Markets Still Pay Double Digits
- Big Tech Is Spending Billions on AIāThese 5 Stocks Are Getting Paid
Receive News & Ratings for PIMCO Senior Loan Active Exchange-Traded Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PIMCO Senior Loan Active Exchange-Traded Fund and related companies with MarketBeat.com's FREE daily email newsletter.
